Trevena to Participate at the H.C. Wainwright Annual Global Investment Conference

Sep 07, 2022 7:00am EDT

Trevena Reports Second Quarter 2022 Results and Provides Business Update

Aug 11, 2022 7:00am EDT

Trevena to Release Second Quarter 2022 Financial Results on August 11, 2022

Aug 08, 2022 7:00am EDT

Trevena, Inc. Announces Closing of Registered Direct Offering of Preferred Stock

Jul 29, 2022 5:27pm EDT

Trevena, Inc. Announces Registered Direct Offering of Preferred Stock

Jul 29, 2022 8:00am EDT

Trevena Announces Positive Topline OLINVYK Cognitive Function Data and Provides General Business Update

Jul 28, 2022 7:00am EDT

Trevena Announces the Publication of an Expert Review on the Clinical Profile of OLINVYK® in Post-Operative Care

Jun 14, 2022 7:00am EDT

Trevena to Participate at the JMP Securities Life Sciences Conference

Jun 10, 2022 7:00am EDT

Trevena to Present at the H.C. Wainwright Global Investment Conference

May 18, 2022 4:05pm EDT

Trevena Reports First Quarter 2022 Results and Provides Business Update

May 11, 2022 7:00am EDT